CIK 0001601485 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113430072
- Phone
- (857) 209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-09 | GANZI VICTOR F Director | Option exercise | +614,310 | $6.43 | $4.0M | 1,069,837 |
| 2021-02-09 | GANZI VICTOR F Director | Sale | −246,720 | $16.00 | $3.9M | 823,117 |
| 2021-02-09 | GANZI VICTOR F Director | Option exercise · Warrant to Purchase Common Stock | −614,310 | 0 | ||
| 2021-02-09 | Venkatesan Jay See Remarks | Shares withheld for taxes | −31,966 | $16.00 | $511K | 1,037,017 |
| 2021-02-09 | Venkatesan Jay See Remarks | Conversion | +165,094 | 1,202,111 | ||
| 2021-02-09 | Venkatesan Jay See Remarks | Option exercise | +237,152 | $6.43 | $1.5M | 1,439,263 |
| 2021-02-09 | Venkatesan Jay See Remarks | Sale | −159,177 | $16.00 | $2.5M | 1,208,086 |
| 2021-02-09 | Venkatesan Jay See Remarks | Conversion | +262 | $11.57 | $3K | 1,280,348 |
| 2021-02-09 | Venkatesan Jay See Remarks | Conversion · Series C Cumulative Convertible Preferred | −1,804 | 0 | ||
| 2021-02-09 | Venkatesan Jay See Remarks | Option exercise · Warrant to Purchase Common Stock | −237,152 | 0 | ||
| 2021-02-09 | Venkatesan Jay See Remarks | Conversion · Convertible Promissory Note | −0 | 0 | ||
| 2021-02-09 | WILSON KAREN J Director | Conversion | +18,718 | $11.57 | $217K | 18,718 |
| 2021-02-09 | WILSON KAREN J Director | Conversion · Convertible Promissory Note | −0 | 0 | ||
| 2021-02-09 | OMENN GILBERT S Director | Conversion | +23,483 | $11.57 | $272K | 42,152 |
| 2021-02-09 | OMENN GILBERT S Director | Conversion | +23,391 | $11.57 | $271K | 65,543 |
| 2021-02-09 | OMENN GILBERT S Director | Conversion | +14,783 | $11.57 | $171K | 80,326 |
| 2021-02-09 | OMENN GILBERT S Director | Conversion · Convertible Promissory Note | −0 | 0 | ||
| 2021-02-09 | OMENN GILBERT S Director | Conversion · Convertible Promissory Note | −0 | 0 | ||
| 2021-02-09 | OMENN GILBERT S Director | Conversion · Convertible Promissory Note | −0 | 0 | ||
| 2021-02-09 | Goldberg Itzhak See Remarks | Shares withheld for taxes | −38,353 | $16.00 | $614K | 2,067,478 |
Page 8 of 9 · 171 trades